Good morning :)
$
₹
CeriBell, Inc

CeriBell, Inc

CBLL

NASDAQ
Asset Logo

CeriBell, Inc

CBLL

NASDAQ
$26.632.41% (+0.62)
$
₹
$26.632.41% (+0.62)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Devices

Small Cap

With a market cap of $1.1B the stock is ranked 2693

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

8.45
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-1.7
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

-64.73%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 8 analysts reports

Buy
8 analysts
Hold
0 analyst
Sell
0 analyst

Price Upside

+13.69%

Earnings Growth

-35.37%

Rev. Growth

+29.72%

See Detailed Forecast

Company Profile

Company Profile

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Abbott Laboratories
ABT
Abbott Laboratories
P/E Ratio
42.94
42.94
1Y Return
9.08%
9.08%
Buy Reco %
82.14
82.14
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
58.29
58.29
1Y Return
17.33%
17.33%
Buy Reco %
76.47
76.47
Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
38.89
38.89
1Y Return
7.43%
7.43%
Buy Reco %
83.33
83.33
Medtronic PLC
MDT
Medtronic PLC
P/E Ratio
25.78
25.78
1Y Return
13.03%
13.03%
Buy Reco %
66.66
66.66
Stryker Corporation
SYK
Stryker Corporation
P/E Ratio
36.17
36.17
1Y Return
7.89%
7.89%
Buy Reco %
76.66
76.66
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

2026
Current$26.01Baseline
Analyst Target - 1 year
Target$29.57+13.69%

All values in $

20232024202520262027$22.93$26.13$29.33Target+13.69%
2026
Current$26.01Baseline
Analyst Target - 1 year
Target$29.57+13.69%

All values in $

Revenue Forecast

Revenue Forecast

Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 29.72% growth, versus a trailing 3-year CAGR of 50.90%.

2025
Current$89.06Baseline
Forecast for Dec 2026
High$116+30.24%
Average$115.53+29.72%
Low$115+29.12%

All values in $ Million

2022202320242025202625.9245.2265.4489.06Low+29.12%Average+29.72%High+30.24%
2025
Current$89.06Baseline
Forecast for Dec 2026
High$116+30.24%
Average$115.53+29.72%
Low$115+29.12%

All values in $ Million

Earnings Per Share Forecast

Earnings Per Share Forecast

2025
Current$-1.47Baseline
Forecast for Dec 2026
High$-1.92-30.61%
Average$-1.99-35.37%
Low$-2.06-40.14%

All values in $

20222023202420252026N/AN/A-2.62-1.47Low-40.14%Average-35.37%High-30.61%
2025
Current$-1.47Baseline
Forecast for Dec 2026
High$-1.92-30.61%
Average$-1.99-35.37%
Low$-2.06-40.14%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

24.7
-13.5
26.4
-19.7
28
-19.2
29.3
-21.3
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Revenue
Net Income
Financial YearQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Total Revenue14.8517.1918.5320.4921.1922.5824.7826.4928.0929.34
Net Income-8.73-10.41-12.57-12.77-13.64-13.46-13.52-19.73-19.26-21.35
Net Profit Margin-58.76%-60.58%-67.85%-62.35%-64.35%-59.60%-54.57%-74.49%-68.57%-72.76%
See CostsAll values in $ Million

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Devices

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
CeriBell, Inc -8.45-
Abbott Laboratories42.943.701.56
Intuitive Surgical Inc58.299.742.04
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare CBLL with any stock or ETF
Compare CBLL with any stock or ETF
Comparing from
CBLL
ABT
ISRG
Loading...

Frequently asked questions

  1. CeriBell, Inc (CBLL) share price today is $26.63 as of November 7, 2026 at 2:29 AM IST. The stock touched a day high of $26.81 and a day low of $25.33.

  2. CeriBell, Inc stock trades on NASDAQ under the ticker symbol CBLL.

  3. CeriBell, Inc's market capitalization is $1.05B as of November 7, 2026 at 2:29 AM IST.

  4. CeriBell, Inc's price-to-earnings (P/E) ratio is N/A as of November 6, 2026.

  5. CeriBell, Inc's price-to-book (P/B) ratio is 8.45 as of November 6, 2026.

  6. Yes, You can buy CeriBell, Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy CeriBell, Inc shares in three steps: 1. Search CeriBell, Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since CeriBell, Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in CeriBell, Inc (CBLL) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.3754 shares at the current price of $26.63.

Loading...